GSDMD and multiple sclerosis: These findings explained the efficacy of DMF as a treatment by directly interrupting the activation of GSDMD for multiple sclerosis and other inflammatory diseases and offer insights into future anti-inflammatory drug design (Humphries et al., 2020).